Hjem › Kronisk lymfatisk leukæmi › Ohio › Cincinnati
Kronisk lymfatisk leukæmi kliniske forsøg i Cincinnati, OH
14 studier for Kronisk lymfatisk leukæmi søger deltagere på steder i og omkring Cincinnati (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- og 3 flere
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RekruttererFase 3
- Oncology Hematology Care Clinical Trials, Llc, Cincinnati
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
RekruttererFase 3
- Saint Elizabeth Healthcare ( Site 0041), Edgewood · 8 mi væk
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekruttererFase 4
- Oncology Hematology Care Inc, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- University of Cincinnati Medical Center, Cincinnati
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekruttererFase 2
- University of Cincinnati, Cincinnati
- Oncology Hematology Care, Fairfield · 15 mi væk
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RekruttererFase 1
- University of Cincinnati, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- University of Cincinnati Medical Center, Cincinnati
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekruttererFase 2
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mi væk
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekruttererFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
RekruttererFase 2
- University of Cincinnati, Cincinnati
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
RekruttererFase 2
- University of Cincinnati, Cincinnati
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
RekruttererFase 2
- University of Cincinnati Medical Center, Cincinnati
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
RekruttererFase 1/2
- University of Cincinnati, Cincinnati
Kronisk lymfatisk leukæmi forsøg i andre byer
- Boston, MA31 studier
- Columbus, OH28 studier
- Durham, NC27 studier
- Washington, DC22 studier
- Seattle, WA20 studier
- Rochester, MN19 studier
- New York City, NY18 studier
- Houston, TX17 studier
- Baldwin Park, CA16 studier
- Milwaukee, WI15 studier
- Chicago, IL14 studier
- Nashville, TN13 studier
Andre studier i Cincinnati
- Ikke-småcellet lungecancer35 studier
- Kræft (alle typer)27 studier
- Brystkræft25 studier
- Hjertesvigt24 studier
- Colorektal kræft21 studier
- Akut myeloid leukæmi20 studier
- Metastatisk cancer20 studier
- Ægstockræft19 studier
- Lungecancer19 studier
- Overvægt19 studier
- Prostatakræft18 studier
- Multipelt myelom17 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.